resveratrol has been researched along with Encephalopathy, Hepatic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Acharjee, A; Bs, SR; Chakraborty, S; Khanna, A; Trigun, SK; Tripathi, SJ | 1 |
Bella, R; Bertino, G; Borzì, AM; Drago, F; Malaguarnera, G; Malaguarnera, M; Motta, M; Pennisi, M; Vicari, E | 1 |
1 trial(s) available for resveratrol and Encephalopathy, Hepatic
Article | Year |
---|---|
Resveratrol in Patients with Minimal Hepatic Encephalopathy.
Topics: Adult; Aged; Antioxidants; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged; Resveratrol; Stilbenes | 2018 |
1 other study(ies) available for resveratrol and Encephalopathy, Hepatic
Article | Year |
---|---|
SIRT1 activation by resveratrol reverses atrophy of apical dendrites of hippocampal CA1 pyramidal neurons and neurobehavioral impairments in moderate grade hepatic encephalopathy rats.
Topics: Animals; Antioxidants; Atrophy; Behavior, Animal; CA1 Region, Hippocampal; Dendrites; Hepatic Encephalopathy; Memory; Motor Activity; Pyramidal Cells; Rats; Resveratrol; Sirtuin 1 | 2020 |